Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 7Leukemia, Myeloid, Acute 5Hepatitis C 5Recurrence 4Hepatitis C, Chronic 4Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Respiratory Tract Infections 2Lymphoma, Mantle-Cell 2Infections 2Head and Neck Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Seminoma 1Respiratory Syncytial Virus Infections 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pneumonia 1Neuroblastoma 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Malignant Solid Tumor 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Methylprednisolone 4Etanercept 2Bronchoscopy 2Bronchoalveolar Lavage 2Blood Specimen Collection 2ziprasidone 1tocilizumab 1pirfenidone 1ceftolozane, tazobactam drug combination 1Zolpidem 1XAV-19 1X-Rays 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1Sodium Bicarbonate 1Sevelamer 1Saline Solution 1Rocuronium 1Ribavirin 1Prednisone 1Piperacillin, Tazobactam Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pneumonia × Ribavirin × Clear all
NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed
48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡